Skip to NavigationSkip to content

7th Annual Developing IP Strategies for Crystalline Forms

Monday, October 24, 2011 - Wednesday, October 26, 2011
7th Annual Developing IP Strategies for Crystalline Forms
London, United Kingdom

Event Type: Conference

The only event of that will directly address the unique challenges involved in patenting crystalline forms


Paul Fehlner, Global Head, Pharma Intellectual Property, Novartis

Eric Ruhlmann, European Patent Attorney, Actelion

Nicolas Ruiz, Head of IP, Esteve

Andre Bourgouin, Chief IP Officer, Ipsen

Raymond Parker, Assistant General Counsel, Vice President of Patents, Aptalis Pharmaceuticals

Richie Paul, Head of IP, Elan Drug Technologies

Bertrand Gellie, Director, European Patent Office

Andrew Bartlett, Deputy Director, Intellectual Property Office

James Smith, Chief of Board of Patent Appeals and Interferences, USPTO

Chris Hayes, Senior Advisor, Intellectual Property Rights - Launched Products, Lundbeck

Bo Hammer Janssen, Senior Patent Counsel, Novozymes

Mandar Kodgule, Head Intellectual Property and Strategic Planning, Wockhardt

James Horgan, Assistant Counsel, Merck

Dr Avajit Kelka, Director, Head IP Management Cell, API and Generics, Dr Reddys Laboratories (UK)

Alastair Wilson QC, Joint Head of Chambers, Hogarth Chambers

Professor Christian Lehmann, Head of Chemical Crystallography and Electron Mictroscopy, Max-Planck Institute

Professor Sally Price, Professor of Physical Chemistry, University College London

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches